2005P-0411 | Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs | |||||||||||||||||||||||
FDA Comment Number : | EC7234 | |||||||||||||||||||||||
Submitter : | Ms. Genevieve Zulia | Date & Time: | 03/06/2006 01:03:11 | |||||||||||||||||||||
Organization : | Ms. Genevieve Zulia | |||||||||||||||||||||||
Category : | Individual Consumer | |||||||||||||||||||||||
Issue Areas/Comments | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
The benefit of BHRT is that it is designed for ME and I am concerned that Wyeth's petition (Docket #2005P-0411) would limit the ability of my physician and pharmacist to keep prescribing and preparing these individualized doses for me. The FDA should reject Wyeth's petition!! | ||||||||||||||||||||||||